Ariad Pharmaceuticals Inc Reportedly receives US approval to bring back Iclusig (Ponatinib) to the US market; sales to begin in January on narrower label terms - financial press
- Reminder: earlier this month chatter circulated that FDA may lift ban on Iclusig